BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kir G, Cetiner H, Karateke A, Gurbuz A, Bulbul D. Utility of MIB-1 and estrogen and progesterone receptor in distinguishing between endometrial stromal sarcomas and endometrial stromal nodules, highly cellular leiomyomas. Int J Gynecol Cancer 2005;15:337-42. [DOI: 10.1111/j.1525-1438.2005.15226.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Borg CS, Humaidan P, Noer H, Majeed HG. Endometrial Stromal Nodule: A Rarity and a Pathological Challenge. Case Rep Obstet Gynecol 2015;2015:376817. [PMID: 26221551 DOI: 10.1155/2015/376817] [Reference Citation Analysis]
2 Feng W, Malpica A, Skaland I, Gudlaugsson E, Robboy SJ, Dalen I, Hua K, Zhou X, Baak JP. Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade? PLoS One 2013;8:e75899. [PMID: 24146786 DOI: 10.1371/journal.pone.0075899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
3 Koivisto-korander R, Scélo G, Ferro G, Mellemkjaer L, Hemminki K, Weiderpass E, Tamaro S, Pompe-kirn V, Tracey E, Brewster DH, Kliewer EV, Tonita JM, Kee-seng C, Jonasson JG, Martos C, Brennan P, Straif K, Pukkala E. Second primary malignancies among women with uterine sarcoma. Gynecologic Oncology 2012;126:30-5. [DOI: 10.1016/j.ygyno.2012.04.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
4 Yoshida Y, Kiyono Y, Tsujikawa T, Kurokawa T, Okazawa H, Kotsuji F. Additional value of 16α-[18F]fluoro-17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET. Eur J Nucl Med Mol Imaging 2011;38:1824-31. [DOI: 10.1007/s00259-011-1851-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
5 Koivisto-korander R, Butzow R, Koivisto A, Leminen A. Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers. Tumor Biol 2011;32:451-9. [DOI: 10.1007/s13277-010-0138-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
6 Lee CH, Ali R, Gilks CB. Molecular Genetics of Mesenchymal Tumors of the Female Genital Tract. Surg Pathol Clin 2009;2:823-34. [PMID: 26838781 DOI: 10.1016/j.path.2009.08.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Kurian RR, Madhuri TK, Butler-manuel S, Micci F, di Palma S. Low grade endometrial stromal sarcoma with epithelial differentiation mimicking endometriosis. Diagnostic Histopathology 2009;15:496-500. [DOI: 10.1016/j.mpdhp.2009.07.007] [Reference Citation Analysis]
8 Lax S. [Mesenchymal uterine tumors. Stromal tumors and other rare mesenchymal neoplasms]. Pathologe 2009;30:284-91. [PMID: 19495764 DOI: 10.1007/s00292-009-1152-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
9 Zagouri F, Dimopoulos AM, Fotiou S, Kouloulias V, Papadimitriou CA. Treatment of early uterine sarcomas: disentangling adjuvant modalities. World J Surg Oncol 2009;7:38. [PMID: 19356236 DOI: 10.1186/1477-7819-7-38] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
10 Mccluggage WG, Robboy SJ. Mesenchymal uterine tumors, other than pure smooth muscle neoplasms, and adenomyosis. Robboy's Pathology of the Female Reproductive Tract 2009. [DOI: 10.1016/b978-0-443-07477-6.50022-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
11 Comunoğlu NU, Durak H, Comunoğlu C, Ekici AI, Ozkan F, Akyildiz EU, Ilvan S, Calay Z, Molinas N. Expression of cyclooxygenase-2, c-kit, progesterone and estrogen receptors in uterine smooth muscle tumors: differential diagnosis. APMIS 2007;115:726-35. [PMID: 17550381 DOI: 10.1111/j.1600-0463.2007.apm_629.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]